NCT01961180View on ClinicalTrials.gov

The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

Cipralex

the dosage is crescendo for one week and descending for two weeks with half dosage, to avoid side effects.

DRUG

Placebo

Placebo

Trial Locations (1)

5000

Department of Endocrinology, Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT01961180 - The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS | Biotech Hunter | Biotech Hunter